BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 28369813)

  • 1. The proprotein convertase furin in tumour progression.
    Jaaks P; Bernasconi M
    Int J Cancer; 2017 Aug; 141(4):654-663. PubMed ID: 28369813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Proprotein Convertase Furin Contributes to Rhabdomyosarcoma Malignancy by Promoting Vascularization, Migration and Invasion.
    Jaaks P; D'Alessandro V; Grob N; Büel S; Hajdin K; Schäfer BW; Bernasconi M
    PLoS One; 2016; 11(8):e0161396. PubMed ID: 27548722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia enhances cancer cell invasion through relocalization of the proprotein convertase furin from the trans-Golgi network to the cell surface.
    Arsenault D; Lucien F; Dubois CM
    J Cell Physiol; 2012 Feb; 227(2):789-800. PubMed ID: 21503879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The proprotein convertases furin and PACE4 play a significant role in tumor progression.
    Bassi DE; Mahloogi H; Klein-Szanto AJ
    Mol Carcinog; 2000 Jun; 28(2):63-9. PubMed ID: 10900462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated furin expression in aggressive human head and neck tumors and tumor cell lines.
    Bassi DE; Mahloogi H; Al-Saleem L; Lopez De Cicco R; Ridge JA; Klein-Szanto AJ
    Mol Carcinog; 2001 Aug; 31(4):224-32. PubMed ID: 11536372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyphenols with indirect proprotein convertase inhibitory activity.
    Zhu J; Van de Ven W; Vermorken A
    Int J Oncol; 2013 Sep; 43(3):947-55. PubMed ID: 23835774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Furin as proprotein convertase and its role in normaland pathological biological processes].
    Solovyeva NI; Gureeva TA; Timoshenko OS; Moskvitina TA; Kugaevskaya EV
    Biomed Khim; 2016 Nov; 62(6):609-621. PubMed ID: 28026803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting proprotein convertases in furin-rich lung cancer cells results in decreased in vitro and in vivo growth.
    Bassi DE; Zhang J; Renner C; Klein-Szanto AJ
    Mol Carcinog; 2017 Mar; 56(3):1182-1188. PubMed ID: 27584082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver-Specific Inactivation of the Proprotein Convertase FURIN Leads to Increased Hepatocellular Carcinoma Growth.
    Declercq J; Brouwers B; Pruniau VP; Stijnen P; Tuand K; Meulemans S; Prat A; Seidah NG; Khatib AM; Creemers JW
    Biomed Res Int; 2015; 2015():148651. PubMed ID: 26167473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of prohepcidin processing and activity by the subtilisin-like proprotein convertases Furin, PC5, PACE4 and PC7.
    Scamuffa N; Basak A; Lalou C; Wargnier A; Marcinkiewicz J; Siegfried G; Chrétien M; Calvo F; Seidah NG; Khatib AM
    Gut; 2008 Nov; 57(11):1573-82. PubMed ID: 18664504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proprotein convertases: "master switches" in the regulation of tumor growth and progression.
    Bassi DE; Fu J; Lopez de Cicco R; Klein-Szanto AJ
    Mol Carcinog; 2005 Nov; 44(3):151-61. PubMed ID: 16167351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of the pro-protein convertase furin predicts decreased survival in ovarian cancer.
    Page RE; Klein-Szanto AJ; Litwin S; Nicolas E; Al-Jumaily R; Alexander P; Godwin AK; Ross EA; Schilder RJ; Bassi DE
    Cell Oncol; 2007; 29(4):289-99. PubMed ID: 17641413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prodomain of the proprotein convertase subtilisin/kexin Furin (ppFurin) protects from tumor progression and metastasis.
    Scamuffa N; Sfaxi F; Ma J; Lalou C; Seidah N; Calvo F; Khatib AM
    Carcinogenesis; 2014 Mar; 35(3):528-36. PubMed ID: 24127186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human carcinoma cell growth and invasiveness is impaired by the propeptide of the ubiquitous proprotein convertase furin.
    López de Cicco R; Bassi DE; Zucker S; Seidah NG; Klein-Szanto AJ
    Cancer Res; 2005 May; 65(10):4162-71. PubMed ID: 15899807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The proprotein convertase furin is required to maintain viability of alveolar rhabdomyosarcoma cells.
    Jaaks P; Meier G; Alijaj N; Brack E; Bode P; Koscielniak E; Wachtel M; Schäfer BW; Bernasconi M
    Oncotarget; 2016 Nov; 7(47):76743-76755. PubMed ID: 27572312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ERBB3-induced furin promotes the progression and metastasis of ovarian cancer via the IGF1R/STAT3 signaling axis.
    Chen C; Gupta P; Parashar D; Nair GG; George J; Geethadevi A; Wang W; Tsaih SW; Bradley W; Ramchandran R; Rader JS; Chaluvally-Raghavan P; Pradeep S
    Oncogene; 2020 Apr; 39(14):2921-2933. PubMed ID: 32029900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Furin is the major proprotein convertase required for KISS1-to-Kisspeptin processing.
    Harihar S; Pounds KM; Iwakuma T; Seidah NG; Welch DR
    PLoS One; 2014; 9(1):e84958. PubMed ID: 24454770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limited redundancy of the proprotein convertase furin in mouse liver.
    Roebroek AJ; Taylor NA; Louagie E; Pauli I; Smeijers L; Snellinx A; Lauwers A; Van de Ven WJ; Hartmann D; Creemers JW
    J Biol Chem; 2004 Dec; 279(51):53442-50. PubMed ID: 15471862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proprotein convertase furin/PCSK3 and atherosclerosis: New insights and potential therapeutic targets.
    Ren K; Jiang T; Zheng XL; Zhao GJ
    Atherosclerosis; 2017 Jul; 262():163-170. PubMed ID: 28400053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A small-molecule furin inhibitor inhibits cancer cell motility and invasiveness.
    Coppola JM; Bhojani MS; Ross BD; Rehemtulla A
    Neoplasia; 2008 Apr; 10(4):363-70. PubMed ID: 18392131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.